BrainCheck Test May Help with Post-COVID Brain Fog

April 13, 2021 / Nueterra Capital Marketing

BrainCheck | A Nueterra Capital Portfolio Company

As reported by Medical Design and Outsourcing, the neurocognitive test developed by Nueterra Capital portfolio company BrainCheck may help identify patients with post-COVID brain fog. The mobile test may also help physicians determine a care plan for patients with post-COVID brain fog, as well as help them track patient cognitive function over time. The test takes 10-15 minutes to complete and factors in the patient’s age in scoring results. BrainCheck Chief Medical Officer Dr. Reza Hosseini Ghomi said the tests will be covered by Medicare and private insurance.  BrainCheck is currently used in over 400 neurology, primary care, and geriatrics practices.